학술논문

Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
Document Type
article
Source
Nature Cell Biology. 25(12)
Subject
Biochemistry and Cell Biology
Biological Sciences
Urologic Diseases
Prostate Cancer
Aging
Cancer
Aetiology
1.1 Normal biological development and functioning
2.1 Biological and endogenous factors
Underpinning research
Male
Humans
Prostate
Monocarboxylic Acid Transporters
Cell Differentiation
Epithelial Cells
Androgen Antagonists
Lactates
Medical and Health Sciences
Developmental Biology
Biochemistry and cell biology
Language
Abstract
Lineage transitions are a central feature of prostate development, tumourigenesis and treatment resistance. While epigenetic changes are well known to drive prostate lineage transitions, it remains unclear how upstream metabolic signalling contributes to the regulation of prostate epithelial identity. To fill this gap, we developed an approach to perform metabolomics on primary prostate epithelial cells. Using this approach, we discovered that the basal and luminal cells of the prostate exhibit distinct metabolomes and nutrient utilization patterns. Furthermore, basal-to-luminal differentiation is accompanied by increased pyruvate oxidation. We establish the mitochondrial pyruvate carrier and subsequent lactate accumulation as regulators of prostate luminal identity. Inhibition of the mitochondrial pyruvate carrier or supplementation with exogenous lactate results in large-scale chromatin remodelling, influencing both lineage-specific transcription factors and response to antiandrogen treatment. These results establish reciprocal regulation of metabolism and prostate epithelial lineage identity.